PTPRC and primitive neuroectodermal tumor: A prevalence of CD45 negative CD56 positive cells, consistent with a neuro-ectodermal population [41], was documented in 13 cases, with a strong CD34 expression identified in the PNET case, suggesting a potential role of FCM in non hematological tumors.